A detailed history of Coastwise Capital Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Coastwise Capital Group, LLC holds 29,539 shares of BMY stock, worth $1.71 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
29,539
Previous 35,755 17.38%
Holding current value
$1.71 Million
Previous $1.48 Million 2.96%
% of portfolio
1.26%
Previous 1.44%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $246,526 - $321,678
-6,216 Reduced 17.38%
29,539 $1.53 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $613,168 - $807,249
15,234 Added 74.24%
35,755 $1.48 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $211,927 - $240,284
4,417 Added 27.43%
20,521 $1.11 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $323,264 - $385,743
-6,668 Reduced 29.28%
16,104 $826,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $134,362 - $150,238
2,321 Added 11.35%
22,772 $1.32 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $120,730 - $134,052
1,895 Added 10.21%
20,451 $1.31 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $36,863 - $41,811
-561 Reduced 2.93%
18,556 $1.29 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $50,538 - $59,844
738 Added 4.02%
19,117 $1.38 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $92 - $54,863
-714 Reduced 3.74%
18,379 $1.31 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $75,089 - $82,699
-1,034 Reduced 5.14%
19,093 $1.47 Million
Q1 2022

Aug 15, 2022

BUY
$61.48 - $73.72 $1.24 Million - $1.48 Million
20,127 New
20,127 $1.47 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Coastwise Capital Group, LLC Portfolio

Follow Coastwise Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastwise Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastwise Capital Group, LLC with notifications on news.